Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized trial of molecularly guided therapy versus empiric cisplatin + gemcitabine in carcinoma of unknown primary (CUP)
2013-004321-83Phase 3Active
- Sponsor
- Institut Català d'Oncologia
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin and gemcitabine in cancer of unknown primary (CUP) (2 arms), sponsored by Institut Català d'Oncologia. Primary endpoint: Progression-free survival. Started Dec 2013; status: active.
02
Drugs
cisplatingemcitabine
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on 2013-004321-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004321-83.